NMR spectroscopy of aminoacylase 1 deficiency, a novel inborn error of metabolism

Aminoacylase 1 deficiency is a novel inborn error of metabolism. The clinical significance of the deficiency is under discussion, as well as the possible consequences of the defect for brain metabolism and function. This study includes the five originally published cases as well as three novel ones. NMR spectroscopy of urine, serum and cerebrospinal fluid has been used to study these patients. A typical profile with 11 accumulating N‐acetylated amino acids was observed in urine from the patients. The concentration of most of the accumulating metabolites is typically 100–500 µmol/mmol creatinine. Two additional minor N‐acetylated metabolites remain unidentified. The concentrations of the accumulating metabolites are <20 µmol/L in serum from the patients. Interestingly we found no evidence of an increased concentration of N‐acetylated amino acids in the cerebrospinal fluid from one patient. Our data define aminoacylase 1 deficiency at the metabolite level providing a specific urinary profile of accumulating N‐acetylated amino acids. Copyright © 2007 John Wiley & Sons, Ltd.

[1]  A. Heerschap,et al.  Defect in dimethylglycine dehydrogenase, a new inborn error of metabolism: NMR spectroscopy study. , 1999, Clinical chemistry.

[2]  S. Seneca,et al.  Aminoacylase I deficiency: a novel inborn error of metabolism. , 2005, Biochemical and biophysical research communications.

[3]  M. Durán,et al.  Physician’s Guide to the Laboratory Diagnosis of Metabolic Diseases , 2003, Springer Berlin Heidelberg.

[4]  N. Izumiya,et al.  Studies on Diastereoisomeric α-Amino Acids and Corresponding α-Hydroxy Acids. VII. Influence of β-Configuration on Enzymic Susceptibility , 1956 .

[5]  I. Harting,et al.  Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF , 2004, Neurology.

[6]  U. Engelke,et al.  Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism , 2003, Annals of clinical biochemistry.

[7]  A Heerschap,et al.  Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. , 1995, Clinical chemistry.

[8]  K. Sugahara,et al.  Liquid chromatographic-mass spectrometric analysis of N-acetylamino acids in human urine. , 1994, Journal of chromatography. B, Biomedical applications.

[9]  L. de Meirleir,et al.  Gas chromatographic-mass spectrometric analysis of N-acetylated amino acids: the first case of aminoacylase I deficiency. , 2006, Analytica chimica acta.

[10]  Eva Morava,et al.  NMR spectroscopic studies on the late onset form of 3‐methylglutaconic aciduria type I and other defects in leucine metabolism , 2006, NMR in biomedicine.

[11]  P. Pouwels,et al.  In vivo and in vitro NMR spectroscopy reveal a putative novel inborn error involving polyol metabolism , 2001, NMR in biomedicine.

[12]  H. Omran,et al.  Mutations in ACY1, the gene encoding aminoacylase 1, cause a novel inborn error of metabolism. , 2006, American journal of human genetics.

[13]  P. Vreken,et al.  β‐Ureidopropionase deficiency: A novel inborn error of metabolism discovered using NMR spectroscopy on urine , 2001, Magnetic resonance in medicine.

[14]  U. Engelke,et al.  N-acetylated metabolites in urine: proton nuclear magnetic resonance spectroscopic study on patients with inborn errors of metabolism. , 2004, Clinical chemistry.

[15]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[16]  F. Sherman,et al.  N-terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins. , 2003, Journal of molecular biology.

[17]  W. Lehnert.  Long-term results of selective screening for inborn errors of metabolism , 2005, European Journal of Pediatrics.